arsenic trioxide has been researched along with Choroid Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedikian, AY; Camacho, LH; Kim, KB; McCullough, C; Papadopoulos, NE | 1 |
| Li, B; Li, WH; Sun, YL; Wang, CF; Xu, YL; Zhang, HY | 1 |
| Agarwala, SS; Gooding, WE; Islam, MF; Kirkwood, JM; Tarhini, AA; Tawbi, H | 1 |
2 trial(s) available for arsenic trioxide and Choroid Neoplasms
| Article | Year |
|---|---|
A phase II trial of arsenic trioxide in patients with metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Choroid Neoplasms; Female; Humans; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Oxides; Skin Neoplasms; Survival Rate; Treatment Outcome | 2005 |
Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Choroid Neoplasms; Drug Administration Schedule; Female; Humans; Male; Melanoma; Middle Aged; Oxides; Skin Neoplasms | 2008 |
1 other study(ies) available for arsenic trioxide and Choroid Neoplasms
| Article | Year |
|---|---|
[In vitro study on inhibition of human choroidal melanoma OCM-1 cell line by arsenic trioxide].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Choroid Neoplasms; Dose-Response Relationship, Drug; Glutathione Peroxidase; Humans; Melanoma; Oxides | 2005 |